Thursday, January 5, 2012

IP Carrier: Is Communications Spending Growing, or Not?

IP Carrier: Is Communications Spending Growing, or Not?

Is Communications Spending Growing, or Not?


As a practical matter, it often is difficult to ascertain whether consumer or business spending on particular communications services or products, though up or down in nominal terms, actually represent growth or decline.

The reason is that nominal increases in spending over time sometimes reflect broader price changes in the whole economy, rather than changes in demand or spending as a percentage of total spending.

Also, even nominal spending can be deceptive. If a flat dollar amount of spending over time also is accompanied by large decreases or increases of overall income, for example, the nominal spending can disguise ?real? changes.

Ignore for the moment changes in product value or features over time that also complicate comparisons. If ?X? amount of spending on any product also is accompanied by significant changes in a household or national budget, for example, then the implications can be quite significant.

As a percentage of spending, a flat amount automatically will represent a larger percentage of spending.

In other words, the product of a fraction always changes as either the nominator or denominator changes.


That noted, it is possible that spending patterns are changing, for the first time in decades. There is evidence that between 2007 and 2010, for example, U.S. households were spending much more on ?telephone equipment,? which has to represent purchases of mobile phones. That should, in principle, lead to higher spending on mobile communication services.

There also was a predictable increase in spending on ?communication services,? which probably reflects increases in video subscription rates, plus some incremental spending on mobile services for all those mobile devices people seem to be buying.

Keep in mind that those percentage increases might, or might not, represent a significant change in the percentage of household spending on services or devices.

Logic might suggest that most people do not spend much, in any given year, on fixed line phones or fax machines, for example.

So a 16-percent change on a small base might not represent much actual sales volume. A four-percent growth of spending on ?information processing? equipment, which presumably includes personal computers, tablets and possibly other personal mobile devices, might represent a bigger change in dollar volume.
On the other hand, logic also would suggest that people are spending more on tablets and smart phones, which could mean they are maintaining spending on legacy products, and adding new devices (increasing spending overall), substituting new products for older products (substituting new products for older products), or cutting back someplace else in budgets to add the new products.?


Looking back at the 1990 to 2008 period, for example, one can note ?huge? increases in nominal consumer spending on communications and information technology.

Since 1990, though, those changes also ?have been more than matched by broader increases in household income, holding the percentage of household spending on communications flat over the entire period.

One might also note that such figures also are not typically ?inflation adjusted? to show changes in constant dollar terms.

Since 1990, consumer spending on information and communications technology has grown from $197 billion to $545 billion, 5.1 percent of national disposable income in 1990, peaking at 5.9 percent in 2000, and falling to 5.4 percent in 2008. Those figures include both recurring spending on services and product purchases.

Spending on communications services has tripled over the same period, from $77 billion to $243 billion, and at 2.3 percent of national disposable income, up from 1.8 percent in 1990 but below its peak of 2.5 percent in 2001

Basically, the story is one of large increases in consumer value. Consumers are spending more on communications and information technology, but a steady percentage of disposable income

Yet consumer value has grown exponentially in the intervening years, one might argue. The problem is that changes in product quality are not reflected in retail price metrics. That is a common ?problem? where we look at software and computing devices, where a constant dollar amount buys more processing power and features every 18 months to 24 months.

U.S. communications expenditures as a share of national disposable income has been flat since 1997, but users have added over 100 million broadband and video connections and over 100 million wireless connections, according to the Bureau of Economic Analysis.

Such potential changes bear watching. It would be a very-big deal indeed if typical consumer spending on communications services and mobile devices were to deviate from their historical patterns in a markedly upward direction.

One might argue we already have seen a slight upward trend, measured as a percentage of total household spending. The other angle is that communications spending always will represent a very-small fraction of overall household spending, dwarfed by housing, food, medical care and other categories, for example.

Source: http://ipcarrier.blogspot.com/2012/01/is-communications-spending-growing-or.html

portland news portland news tibetan mastiff manny pacquiao pacquiao blanche blanche

Wednesday, January 4, 2012

Apple & Google Dominate Smartphone Market During 2011

Posted on January 2, 2012 10:50 AM by Rob Williams

We've been talking about smartphone trends quite a bit lately, but with 2011 behind us, there's no better time to take a look at the overall growth (or losses) experienced by some companies through the year. It's of little surprise that both Apple and Google dominated the share, but it comes at the expense of RIM and Microsoft. Palm? Non-existent, as far as comScore is concerned.

Over the course of the past 18 months, Apple's marketshare increase was 4.5% while Google's was a mind-blowing 27.3% - that's more than one-fourth of the entire market captured in a mere 18 months. While Apple's 4.5% seems pale in comparison, its marketshare has already remained impressive for some time, so growth has naturally slowed. Combined, Apple and Google command 75.6% of the smartphone market.

During the same period, RIM has experienced a constant decline, starting off with a 37.6% share but since dropping down to 19.7%. Ouch. Likewise, Microsoft's already paltry 10.8% share dropped to 5.7%.

Given these numbers, 2012 should be an interesting year for the smartphone market because it's hard to predict where things can go from here. Will Android continue to dominate while taking share away from Apple? Will Microsoft finally strike back and see its first increase in at least 18 months? Will we ever see a webOS phone added to the list? We'll have answers to all of these questions in roughly 365 days!


Recent Tech News

Recent Site Content

Source: http://feedproxy.google.com/~r/TechgageNews/~3/vvWuhIJVAfE/apple_google_dominate_smartphone_market_during_2011

matilda new jersey weather halloween movies halloween movies new york snow new york snow braxton miller

The Eames', IBM, and the Dawn of Computing [Video]

What do you do if you're IBM in the 1950s and need to market your behemoth computing machine to a conservative public? Commission a 10-minute informative short to designers Charles and Ray Eames, of course! "The Information Machine" was the result of a unique collaboration that aimed at naturalizing the computer within the context of civilization's intellectual history and American consumerism?-no easy feat. More »


Source: http://feeds.gawker.com/~r/gizmodo/full/~3/vzbVeFd0c-k/the-eames-ibm-and-the-dawn-of-computing

personhood herman cain press conference joe frazier dead joe frazier dead topamax lexapro trazodone

Revive Old Shoelaces By Cutting Them Down and Making Your Own Plastic Tip [DIY]

Revive Old Shoelaces By Cutting Them Down and Making Your Own Plastic TipShoelaces stretch out over time and end up being too long to be single knotted, which is an annoyance most of just deal with. Instructables user 2xlbu4u found a simple way to shorten laces without ruining them.

With a small piece of cheap heat shrink tubing, you make a new plastic tip and then cut down the laces to your desired size. Once the plastic is where you want it, shrink the plastic nub on with the heat shrinker. The end result looks exactly like a new pair of laces would, but with a nice, custom length that will fit your shoes properly. Find the guide over on Instructables with a few added tips to getting it right.

How to Shorten Your Shoelaces When They've Become Too Long to Single Tie | Instructables

Source: http://feeds.gawker.com/~r/lifehacker/full/~3/7XcL5Bvf6-g/revive-old-shoelaces-by-cutting-them-down-and-making-your-own-plastic-tip

ian stewart odom colt mccoy vt vt cleveland browns fred thompson

Tuesday, January 3, 2012

wnep: Graffiti Found at Little League Complex: It was not the happiest of new years for members of one community orga... http://t.co/ay1341CM

  • Passer la navigation
  • Twitter sur votre mobile ? Cliquez ici m.twitter.com!
  • Passer cette ?tape
  • Connexion
Loader Twitter.com
  • Connexion
Graffiti Found at Little League Complex: It was not the happiest of new years for members of one community orga... bit.ly/uFBAXy wnep

Pied de page

Source: http://twitter.com/wnep/statuses/153602528171405313

regis philbin last show ray lewis crystal cathedral sarah vowell fire in reno kelly ripa reno wildfire

Wednesday, December 7, 2011

FDA revisits safety of newer birth control drugs

(AP) ? Birth control drugs that were heavily promoted as having fewer side effects and the ability to clear up acne and other hormonal bothers are under new scrutiny from safety regulators.

Research suggesting that newer birth control formulations are more likely to cause blood clots than older drugs has prompted the Food and Drug Administration to consider new safety measures in meetings later this week. The increased risk is slight but significant because blood clots can cause heart attacks, strokes and blockages in lungs or blood vessels, which can be fatal.

Regulators could order new warning labels on several contraceptives that gained popularity in the last decade, including Bayer's pill Yaz, which was the best-selling birth control pill in the U.S. for 2008 and 2009.

Yaz, its Bayer precursor Yasmin, and similar drugs use a version of a female hormone that appears to reduce side effects found in older drugs, including bloating and mood swings.

On Tuesday, a judge unsealed several court documents suggesting Bayer may have withheld data from FDA about the blood clots risks of its drugs. The documents stem from expert opinion gathered by personal injury lawyers suing Bayer on behalf of patients.

According to one document, Bayer drafted a white paper in 2004 to address "FDA concerns," about clots with Yasmin. An early draft indicated that reports of blood clots with Yasmin were significantly higher than those for three other oral contraceptives. But that information was not included in the final paper submitted to the FDA, and instead the company said a more definitive study of blood clot risk would be forthcoming. That study did not show an increased risk.

"Based on the information that I have reviewed, and it is my opinion, that Bayer presented a selective view of the data, and that presentation obscured the potential risks associated with Yasmin," wrote Dr. David Kessler, a former FDA commissioner, in his expert testimony. Kessler was paid for his time and opinion by the plaintiffs' lawyers.

The FDA declined to accept the court documents for this week's hearings, saying the deadline for submissions was last month, according to an emailed message from an agency officer.

Messages were left with Bayer seeking comment on the documents.

Bayer AG spent more than $270 million on TV and magazine advertisements for Yaz between 2007 and 2010, according TNS Media Intelligence. Such big-budget campaigns are rare for birth control products. One advertisement featured young women singing the Twisted Sister anthem, "We're Not Gonna Take It," while popping balloons labeled "moodiness," ''bloating" and "acne."

Sales of Yaz have fallen since regulators forced Bayer to correct advertisements that overstated Yaz's benefits and as safety questions drew scrutiny in both the U.S. and Europe.

FDA also is reviewing research on clot risks associated with Johnson & Johnson's weekly Ortho Evra patch, which is marketed as an "option for busy women who are looking to simplify life." The drug uses a different version of the female hormone progestin than the pills under scrutiny.

Millions of women have used the products since they launched a decade ago, but recent studies comparing the medical histories of women taking the newer drugs to older ones suggest a slightly higher risk of blood clots in the legs and lungs. Last year, the U.S. market for female contraceptive drugs totaled $3.4 billion, according to IMS Health.

Sorting out the blood clot risk of birth control drugs is especially difficult because all hormone-based drugs increase the risk of clotting. Further complicating the issue is that clots can be caused by factors such as smoking, obesity or family history.

Yaz, Yasmin and other pills containing a synthetic hormone called drospirenone are the focus of a discussion Thursday. The next day's meeting focuses on the Ortho Evra patch, which uses the hormone norelgestromin.

Bayer says its studies have shown no difference in blood clot risk between its drugs and the older birth control drugs. But several large, independent studies suggest the risk with Yaz and similar medications is slightly higher. The latest analysis by the FDA estimates the risk of a blood clot with drospirenone-containing pills is 1.5-fold higher than other hormone-based contraceptives. That translates into an estimated 10 in 10,000 women on the newer drugs experiencing a blood clot, compared with 6 in 10,000 women on older contraceptives, according to the FDA.

"It's a very small percentage of patients that develop these, but it's such a serious side effect that I think doctors have to use a lot of caution," said Dr. Jennifer Wu, of Lenox Hill Hospital in New York.

Even if Yaz and other newer drugs get additional warning labels, some doctors say they don't expect to stop prescribing them. Doctors say the risk of blood clots with any birth control pill is still far lower than that associated with pregnancy and birth, when hormone levels and reduced blood flow increase clotting risk.

"At the end of the day I tell my patients the absolute risk is still very, very low compared to pregnancy and post-partum risk," said Dr. Rebecca Starck, of Cleveland Clinic's Fairview Hospital. "There are still many benefits to combination birth control pills."

The Ortho Evra patch already carries warning labels about an increased risk of blood clots compared with pills. Some, but not all, studies suggest patch users have twice the risk of clots. The FDA will try to further define that risk using the latest data.

Most birth control drugs use a combination of two female hormones, estrogen and progestin, to stop ovulation and help block sperm. But for decades many women have reported bloating and mood swings as side effects.

Introduced in 2001, Yasmin was the first birth control pill to use a new form of progestin called drospirenone, which appeared to have fewer side effects. The reformulated version of the drug, Yaz, was approved in 2006 with new claims on the label that it decreased acne and a severe type of mood disorder.

Yaz quickly grew into the best-selling birth control pill in the U.S. Sales plummeted more than 50 percent in 2010, after the company was forced to run corrective TV and magazine advertisements. Among other problems, the FDA said the company's commercials suggested Yaz could treat premenstrual syndrome when it has only been shown to decrease incidence of premenstrual dysphoric disorder, a severe mood disorder associated with major depression. Less than 8 percent of U.S. women experience the disorder, according to the National Institutes of Health.

Yaz currently ranks fourth in sales among contraceptive pills in the U.S. Last year doctors wrote roughly 13 million prescriptions for Yaz and two generic versions of the drug, according to IMS Health. Doctors prescribed the Ortho Evra patch nearly 1.6 million times.

Newer drugs like Yaz are no more effective than older pills, generally allowing one unplanned pregnancy per year for every 100 women.

"Many women will do fine on the older generation drugs, but some women will not," said Dr. Petra Casey, of the Mayo Clinic. "I think the newer drugs help many women in terms of mood and the water retention."

About 4,000 lawsuits against Bayer argue that any additional risk with the newer drugs should have been detected and emphasized to the public.

On Thursday, Cindy Rippee will tell the FDA panel about her 20-year-old daughter, Elizabeth, who died Christmas Eve 2008 when a blood clot traveled to her lung. Rippee says her daughter had been taking Yasmin for about two months.

"I really feel that if my daughter had been told about the increased risk she would have made a different decision," said Rippee, of Escondido, Calif.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/f70471f764144b2fab526d39972d37b3/Article_2011-12-05-Birth%20Control-Safety/id-e371ac779e494d1da89d550291cdcb72

muhammad ali unemployment rate unemployment rate pentatonix nicki minaj barbie doll nicki minaj barbie doll hazing